International Society for Advancement of Cytometry

EIN: 850319221 501(c)(3) Medical Research

Washington, DC

Total Revenue
$2,881,502
Total Expenses
$2,897,444
Total Assets
$3,492,402
Net Assets
$2,813,371
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1980
Legal Domicile
DC
Principal Officer
Jessica Homa
Phone
7035377948
Tax Period
2024-01-01 to 2024-12-31

International Society for Advancement of Cytometry, founded in 1980, is a community nonprofit in the Medical Research sector that reported $2.9M in total revenue in fiscal year 2024. Revenue grew 9% year-over-year, indicating healthy expansion.

Mission

To serve a multidisciplinary community by leading technological innovation scholarship and the exchange of knowledge in the quantitative cell sciences.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $34,530
Program Service Revenue $2,546,423
Investment Income $214,413
Other Revenue $86,136
TOTAL REVENUE $2,881,502

Expense Breakdown

Grants Paid $21,226
Salaries & Benefits $515,459
Fundraising Expenses $0
Program Expenses $2,425,740
Other Expenses $2,360,759
TOTAL EXPENSES $2,897,444

Year-over-Year Comparison

2024 2023 Change
Revenue $2,881,502 $2,645,391 +0.1%
Expenses $2,897,444 $2,214,769 +0.3%
Net Income $-15,942 $430,622 -1.0%
Key Indicators
Grants to Organizations Grants to Individuals Lobbying Political Activity Foreign Activities Donor Advised Fund Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
15
Independent Members
15
Employees
8
Volunteers
N/A

Governance Policies

Conflict of Interest Policy
Whistleblower Policy
Document Retention Policy

Special Practices & Reported Activities

Operated a School
Operated a Hospital
Provided First Class Travel
Reported Conflict of Interest
Reported Asset Diversion
Excess Benefit Transaction
Made Political Expenditures
Engaged in Lobbying
Operated Donor Advised Fund
Maintained Art Collections
Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
7
$138,829
Total Directors
15
$0
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
Jessica P Houston President 10.00
Officer Director
$0 $0 $0
Virginia Litwin President-Elect 10.00
Officer Director
$0 $0 $0
Jonni Moore Past-President 10.00
Officer Director
$0 $0 $0
Jessica Back Treasurer 10.00
Officer Director
$0 $0 $0
Jonathan Irish Secretary 10.00
Officer Director
$0 $0 $0
Gelo Dela Cruz Councilor 5.00
Director
$0 $0 $0
Cherie Green Councilor 5.00
Director
$0 $0 $0
Matthew Linden Councilor 5.00
Director
$0 $0 $0
Helen Mcguire Councilor 5.00
Director
$0 $0 $0
Joel Sederstrom Councilor 5.00
Director
$0 $0 $0
Josef Spidlen Councilor 5.00
Director
$0 $0 $0
Vera Tang Councilor 5.00
Director
$0 $0 $0
Gert Van Isterdael Councilor 5.00
Director
$0 $0 $0
Rachael Walker Councilor 5.00
Director
$0 $0 $0
Maggie Wang Councilor 5.00
Director
$0 $0 $0
Courtney Brooks Kamin Exec Director thru May 2024 45.00
Officer
$129,686 $9,143 $138,829
Susan Reardon Interim Exec Director May 2024- 45.00
Officer
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 No data No data No data No data
2024 $2,881,502 $2,897,444 $3,492,402 $-15,942
2023 $2,645,391 $2,214,769 $3,293,781 $430,622
2022 $2,605,144 $2,490,977 $2,802,646 $114,167
2021 $1,271,377 $1,593,134 $2,250,621 $-321,757
2020 $881,784 $1,440,579 $2,536,199 $-558,795
2019 $2,328,078 $2,241,239 $3,223,253 $86,839
2018 $2,094,269 $1,898,838 $2,644,803 $195,431
Explore More Nonprofits
Top 100 Nonprofits in District of Columbia Largest U.S. Nonprofits Best Rated Nonprofits Most Efficient Nonprofits

Compare International Society for Advancement of Cytometry with other nonprofits in District of Columbia and across the country.